We would like to congratulate Mesoblast Limited and CEO silviu itescu, on the FDA approval of the first MSC-based therapy for steroid-refractory acute graft-versus-host disease. Pluri CEO and President Yaky Yanay said: “This milestone is not just a triumph for Mesoblast, but for the entire field of cellular medicine... This approval validates the immense therapeutic promise of MSCs and inspires all of us working in this space to redouble our efforts to bring innovative solutions to patients in need.” Read the full release here: https://lnkd.in/dKGP8X5V #celltherapy #pharma #congratulations #innovation
עלינו
Pluri is pushing the boundaries of science and engineering to create cell-based products for commercial use and is pioneering a biotech revolution that promotes global wellbeing and sustainability. The Company’s technology platform, a patented and validated state-of-the-art 3D cell expansion system, advances novel cell-based solutions for a range of initiatives— from medicine and climate change to food scarcity, animal cruelty and beyond. Pluri’s method is uniquely accurate, scalable, cost-effective, and consistent from batch to batch. Pluri currently operates in the field of regenerative medicine and food-tech and aims to establish partnerships that leverage the company’s 3D cell-based technology to additional industries that require effective, mass cell production. To learn more, visit us at www.pluri-biotech.com or follow us on LinkedIn and Twitter.
- אתר אינטרנט
-
http://www.pluri-biotech.com
קישור חיצוני עבור Pluri
- תעשייה
- Biotechnology Research
- גודל החברה
- 51-200 עובדים
- משרדים ראשיים
- Haifa
- סוג
- חברה ציבורית
- הקמה
- 2003
- התמחויות
מיקומים
-
הראשי
MATAM Park, Bldg #5
Haifa, 31905, IL
עובדים ב- Pluri
-
Arthur Machlenkin
CSO at Pluri
-
Yaky Yanay
CEO and President at Pluri (Nasdaq, TASE: PLUR) - Pluri is pushing the boundaries of science and engineering to produce cell-based products
-
Maital (Shemesh) Rasmussen
Chief Commercial Officer | Board Director | Health-Tech Executive | Growth and Revenue at Scale | Octave, Roche, Oracle…
-
Michal sheleg
VP Clinical Development at Pluri-biotech
עדכונים
-
Pluri פרסם מחדש את זה
We are happy to announce that Dr. Barak Zohar, our CTO will be speaking at the 3rd Annual Meat Evolution Leaders Summit 2025 Kenzie Barnett Patrick Basanez GBX EVENTS
-
Cocoa prices have hit a new record high, creating significant challenges for chocolate makers and consumers worldwide 🍫 At Pluri, we are deeply aware of the instability in agricultural markets like cocoa—an unpredictability we also observe in the coffee market. Volatile weather patterns, supply chain disruptions, and global deficits continue to impact producers, businesses, and consumers alike. Challenges like these call for innovative, reliable solutions which is why we leverage our cell expansion technology to navigate instability, build stronger supply chains, and ensure sustainable growth. Read more about the latest cocoa market trends here: https://lnkd.in/dN2DrHgf #Sustainability #CocoaMarket #AgricultureSolutions #Pluri #ResilientMarkets Mark Butterfield
Cocoa Hits New Record in Blow to Chocolate Makers and Consumers
finance.yahoo.com
-
We are happy to share CEO and President Yaky Yanay's recent presentation at the Investor Summit Virtual Microcap Forum, where he discussed Pluri's innovation across multiple industries, the company's latest achievements and goals for 2025. Link to the full webcast in the comments ⬇️ #Investor #financial #biotechnology #innovation Investor Summit Group MAIA Biotechnology, Inc. Vlad Vitoc, MD, MBA Orion Energy Systems, Inc. LM Funding America Beneficient Thermal Energy International William Crossland NEWTON ABBOT (STOVER) GOLF COMPANY LIMITED
-
Pluri was recently featured in Investing.com’s article “3 Biotech Stocks Set to Skyrocket in 2025”. The article highlights our readiness to scale production of PLX-R18, the innovative strides of our subsidiary Ever After Foods, and the strength of our infrastructure and IP portfolio. According to the article "Pluri is a Must-Watch: Pluri’s ability to scale production, combined with its relevance in the current geopolitical landscape, sets it apart as one of the most compelling biotech stocks of 2024." Read the article here: https://lnkd.in/dGHPsu7T #Biotech #Innovation #Undervalued #Pluri
-
We are honored to be shortlisted for the CMDO of the Year Award at the prestigious Advanced Therapies Awards 2025! This recognition highlights the incredible work being done across the advanced therapies industry, and we’re proud to stand alongside so many inspiring leaders, innovators, and organizations shaping the future of cell and gene therapy, regenerative medicine, and biopharmaceuticals. A huge thank you to the Advanced Therapies Awards team for this acknowledgment, and congratulations to all the other amazing finalists. Good luck to everyone competing—may the best CMDO win! 💪✨ #ATA25 #Innovation #Leadership #AdvancedTherapies #CellAndGeneTherapy #RegenerativeMedicine Phacilitate Lior Raviv Nimrod Bar Zvi Andy Lewin Yaky Yanay
🎉 The 2025 Advanced Therapies Awards Shortlist Is Here! 🎉 We’re excited to unveil the incredible finalists for the Advanced Therapies Awards 2025, representing the very best in cell and gene therapy, regenerative medicine, and biopharmaceutical innovation. These trailblazers are shaping the future of advanced therapies, driving breakthroughs that redefine possibilities in science and healthcare. This year’s shortlist showcases extraordinary achievements across the industry, from groundbreaking therapies to cutting-edge technologies. ✨ What’s next? Winners will be announced at the prestigious Advanced Therapies Awards at Union Station Wolfgang Puck on Wednesday, January 22. Join us for an unforgettable evening of celebration, connection, and recognition! 📅 Don’t Miss Out! Secure your tickets now to be part of the action. Early bird pricing ends Friday, December 13, and with limited availability, we expect the event to sell out quickly. 🎟 Book today: https://lnkd.in/eybY8jmQ Let’s celebrate the leaders shaping the future of advanced therapies—see you there! 🚀 #ATA25 #Innovation #CellandGeneTherapy #RegenerativeMedicine #Leadership Uniphar Group Cryoport Systems Catalent Pharma Solutions Marken OrganaBio Resilience CoJourney Akadeum Life Sciences, Inc. BioLife Solutions, Inc. Partners4Access Cellular Origins Phio Pharmaceuticals Corp. Cellares EVast Bio Inc. VIVEbiotech Forge Biologics Pluri SK pharmteco Kudo Biotechnology Nanoscope Therapeutics Inc. Exothera Charles River Laboratories Group IASO BioRestorative Therapies, Inc. Poseida Therapeutics, Inc. AviadoBio INCELL Corporation GC Cell Siren Biotechnology NKILT Therapeutics, Inc. KOMO BIOSCIENCES Orchestra Life Sciences BlueWhale Bio The Medicine Maker Foundation for Angelman Syndrome Therapeutics Regeneron
-
From coffee and cocoa to vanilla and rice, climate change and population growth are putting immense pressure on our food supply. Severe weather, droughts, and rising temperatures are slashing crop yields and driving prices higher. At Pluri, we believe agtech holds the key to tackling these challenges. By cultivating key ingredients in controlled environments, we’re helping secure a stable food future for a growing world. ☀️🔬🌿 Read more about the challenges and solutions shaping the future of food, in this article written by our Chief Commercial Officer Nimrod Bar Zvi for Food Industry Executive: https://lnkd.in/d3VFuhVF #Agtech #Sustainability #Innovation #FoodSecurity #FutureofFood Professor Ari Zoldan Quantum Media Group, LLC
New Technology Addresses At-Risk Commodity Ingredients
https://foodindustryexecutive.com
-
This season, we're grateful for the amazing cells that make up life and the connections that bring us together. Just as every cell plays a vital role, so does every person in our community. Here's to celebrating life, health, and the bonds that unite us all 🍁🦃 #HappyThanksgiving
-
Proud to be part of this amazing company!!
We’re honored to, once again, be named one of Dun & Bradstreet’s Dun's 100 Best HighTech Companies to Work For! 🎉 At Pluri, our employees are the heart of everything we do. Their dedication and innovation drive our success, and we’re proud to continue creating a workplace where they can thrive. Thank you to our incredible team for making this recognition possible, year after year. Here’s to growing together and achieving even more! 🚀 https://lnkd.in/dn_N-YN #TeamPluri #InnovationCulture #Duns100 #BestPlacesToWork Nili Schilling Nofar Glaich
-
We’re honored to, once again, be named one of Dun & Bradstreet’s Dun's 100 Best HighTech Companies to Work For! 🎉 At Pluri, our employees are the heart of everything we do. Their dedication and innovation drive our success, and we’re proud to continue creating a workplace where they can thrive. Thank you to our incredible team for making this recognition possible, year after year. Here’s to growing together and achieving even more! 🚀 https://lnkd.in/dn_N-YN #TeamPluri #InnovationCulture #Duns100 #BestPlacesToWork Nili Schilling Nofar Glaich